Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure

Archives of Internal Medicine

Volumn 159, Issue 3, 1999, Pages 257-261

  Stewart, Simon ^a   Vandenbroek, Annette Joy ^a   Pearson, Sue ^a   Horowitz, John David ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOME CARE; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0033535131     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.3.257     Document Type: Article

References (36)

1. Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:293-302.
2. Captopril Multicentre Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2:755-763.
3. Pfeffer MA, Braunwald E, Moyle LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement (SAVE) trial. N Engl J Med. 1992;327:669-677.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325:293-302.
6. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990's: evolution ot a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993; 22(supplA):3A-5A.
7. Hennen J, Krumholz HM, Radford MJ. Twenty most frequent DRG groups among Medicare inpatients age 65 or older in Connecticut hospitals, fiscal years 1991, 1992, and 1993. Conn Med. 1995;59:11-15.
8. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993;14:1158-1162.
9. Australian Institute of Health and Welfare. Australian Hospital Statistics 1995-96. Canberra, Australia: Australian Institute of Health and Welfare; 1997. Health Services Series No. 10.
10. Croft JB, Giles WH, Pollard RA, Casper ML, Anda RF, Livengood JR. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc. 1997;45:270-275.
11. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968-974.
12. Mark DB. Economics of treating heart failure. Am J Cardiol. 1997;80(8B):33H-38H.
13. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4, suppl A):6A-13A.
14. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157: 2460-2464.
15. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157: 99-104.
16. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc. 1985;33:595-601.
17. Naylor M, Brooten D, Jones R, Lavizzo-Mourey R, Mezey M, Pauley M. Comprehensive discharge planning for the hospitalized elderly. Ann Intern Med. 1994; 120:999-1006.
18. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270-276.
19. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
20. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38: 1290-1295.
21. Graves EJ. 1989 Summary: National Hospital Discharge Survey. Hyattsville, Md: National Center for Health Statistics; 1991. Advance Data From Vital and Health Statistics, No. 199.
22. Burns RB, McCarthy EP, Moskowitz MA, Ash A, Kane RL, Finch M. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc. 1997; 45:276-280.
23. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmissions and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-732.
24. Edep ME, Shah NB, Tateo IM, Massie BM. Difference between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518-526.
25. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997; 80(8B):45H-52H.
26. Reis SE, Holubkov R, Edmundowicz D, et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 1997;30:733-738.
27. Stevenson W, Stevenson L, Middlekauff H, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 1995;26:1417-1423.
28. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158:1067-1072.
29. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of a home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc. 1998;46:174-180.
30. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;333:523-533.
31. Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107-1114.
32. Lowe JM, Candlish PM, Henry DA, Wlodarcyk JH, Heller RF, Fletcher PJ. Management and outcomes of congestive heart failure patients: a prospective study of hospitalised patients. Med J Aust. 1998;168:115-118.
33. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 1996;335:775-782.
34. Swahn E, Wallentin L, for the FRISC Study Group. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). Am J Cardiol. 1997;80(5A):25E-29E.
35. Stewart S, Davey M, Desanctis M, et al. Home medication management: a study of patient post-hospitalisation. Aust Pharmacist. 1995;14:472-476.
36. Alessi CA, Stuck AE, Aronow HU, et al. The process of care in preventive in-home comprehensive geriatric assessment. J Am Geriatr Soc. 1997;45:1044-1050.